Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Turns out it is illegal for a conspiracy of funds to buy and naked sort an offering when they work together all while trading inside information. This group of funds did this multiple times between 2022 RS and 2024 RS.
This is essentially how the Anson family of funds (is Anson at the top of this family?) work SINT and its offerings.
Here is a trade that is almost guaranteed to make money, though it is also double super illegal.
This right here is most likely how this family of funds worked. 1+ of them would get information of a forthcoming offering which it would later participate in, and tip the others off so they can pre-short. Not sure why the author says pre-short, wouldnt this be naked shorting? They then used the shares from the offering that Fund #1 received to cover those naked short positions?
There is definitely evidence supporting this, especially between 2022 RS & 2024 RS. For instance, Lind Group participated in the offering, these funds naked shorted from as high as .50s before Lind used their shares to cover those shorts at .15. Thus this group of funds "laid off their risk", making millions in a few days, and did in fact work as an intermediary between the company and the public as they dumped shares. Lind Group sold off its shares in a matter of days. This group of investors gets a hell of alot more than 10% off these offerings. After factoring in the 200:1 split theyve been shorting since 100 with a hell of a pump and dump between .04 to .22 pre-split (8-44 post split).
The following will show there has in fact been a conspiracy of funds, shorting and distorting SINT & Sintx for the past 9 years. My next post will give some insight into how this family of funds might operate. A third post will show that they target vulnerable but promising companies with valuable assets they can secure significant profits from.
Its worth noting that 3 of the family of funds appear to be accumulating a position, just like what was done to Nano in its lawsuit against this conspiracy of funds. Which means they could be getting ready to make their move. Look how it accumulated its position in Nano and then realize three of its family of hedge funds is currently accumulating positions: Anson Funds Management LP, L1 Capital Global Opportunities Master Fund, Ltd. , Lind Global Fund II LP .
https://i.imgur.com/gRnIWov.jpeg
Conspiracy of Funds
First off lets establish the conspiracy of funds working together. Fortunately, in another unrelated lawsuit, the list has been provided:
Well, technically I didn't address him...just the board in case someone stumbles upon it, thinking it's a good investment, based on the statement I quoted by the individual. But, I do appreciate your thoughts. They haven't gone unnoticed.
why do you waste your breath? you are trying to reason with an obstinate, obssessed loser ....
Oh, brother! Meanwhile, the EXACT OPPOSITE has occurred for EVERY investor since the stock began trading....only a 10 year ongoing trend.
This is essentially how the Anson family of funds (is Anson at the top of this family?) work SINT and its offerings.
Here is a trade that is almost guaranteed to make money, though it is also double super illegal.
This right here is most likely how this family of funds worked. 1+ of them would get information of a forthcoming offering which it would later participate in, and tip the others off so they can pre-short. Not sure why the author says pre-short, wouldnt this be naked shorting? They then used the shares from the offering that Fund #1 received to cover those naked short positions?
There is definitely evidence supporting this, especially between 2022 RS & 2024 RS. For instance, Lind Group participated in the offering, these funds naked shorted from as high as .50s before Lind used their shares to cover those shorts at .15. Thus this group of funds "laid off their risk", making millions in a few days, and did in fact work as an intermediary between the company and the public as they dumped shares. Lind Group sold off its shares in a matter of days. This group of investors gets a hell of alot more than 10% off these offerings. After factoring in the 200:1 split theyve been shorting since 100 with a hell of a pump and dump between .04 to .22 pre-split (8-44 post split).
Notice that on April 1st, L1 filed its 13G indicating it had 8.8% of outstanding stock. Two days later, Sintx announces an offering at 2.1 cents adding 71m shares of stock.
Once this offering completed, L1 stake in Sintx became 3.6%.
This indicates that Sonny is not simply raising funds, but that hes preventing these funds from accumulating too large of a position. Thus this game of massive dilution and reverse splits seems to be a game of Sonny defending Sintx from this group of hostile funds. As long as this group of funds continue to attempt to take over Sintx through hostile means, we can expect this to continue. However with Nasdaq putting Sintx on probation for a year, it's limited on its ability to raise funds while diluting this groups position as it must stay over $1. Sintx needs to do a private placement offering which is likely why Sonny has indicated that Sintx is exploring Strategic Opportunities. Sell Sintx Armor to NP Aerospace is one option as NP Aerospace needs a US facility and Utah is a good location for manufacturing and military connections. It could also try to get one of its partners to take a stake. As Ansons group of funds come at you sideways, they'll try to disrupt any such negotiations. Sintx is in a precarious predicament right now. Can Zimmer Biomet not step up already?
SINTX Technologies to Explore Strategic Opportunities
The following will show there has in fact been a conspiracy of funds, shorting and distorting SINT & Sintx for the past 9 years. My next post will give some insight into how this family of funds might operate. A third post will show that they target vulnerable but promising companies with valuable assets they can secure significant profits from.
Its worth noting that 3 of the family of funds appear to be accumulating a position, just like what was done to Nano in its lawsuit against this conspiracy of funds. Which means they could be getting ready to make their move. Look how it accumulated its position in Nano and then realize three of its family of hedge funds is currently accumulating positions: Anson Funds Management LP, L1 Capital Global Opportunities Master Fund, Ltd. , Lind Global Fund II LP .
https://i.imgur.com/gRnIWov.jpeg
Conspiracy of Funds
First off lets establish the conspiracy of funds working together. Fortunately, in another unrelated lawsuit, the list has been provided:
So Lets examine the value of Sintx and its IP here from a few angles. This should show exactly why Anson's family of funds would be trying to take over Sintx through hostile means. It represents alot of potential money for them if they can succeed. A work in progress.
Transitive Property:
In 2003, Zimmer acquired a materials company for $232m with $108m of it upfront and the remaining $124m coming over the next two years based on sales milestones. Before announcing its partnership with Zimmer, Implex had revenue about the same as Sintx should achieve this year. Its material Hydrocel, Trabeular Metal, could be used for multiple orthopedic implants. Spine, dental, hip, shoulder, and i think knee. That said, Trabecular metal cannot be used as a coating or imbued in materials like silicon nitride can to bring those materials its beneficial enhancements. Thus its market potential just in ortho/dental markets is smaller
Thus Sintx valuation should be at minimum based on what similar companies are worth: $232m
Accumulated Deficit and Tax Write-off
Sintx Accumulated Deficit = $271.6m. For an acquiring company to utilize this for tax write off purposes Sintx IP would have to be valuable enough to bring in sufficient revenue. However as the cost to acquire Sintx would cost millions between accounting audits, lawyers, golden parachutes, etc.. Sintx accumulated Deficit would likely represent about the same value as what Implex was acquired for to an acquiring company. That is only if Sintx IP couldnt generate more revenue than Sintx deficit. The following will show that it can easily.
Also, acquiring Sintx for that amount would increase goodwill which is an asset the acquiring company can depreciate and thus provide additional tax benefit as well as increase its assets.
Potential Market Size
One particular thing about Sintx is its current sales represents a fraction of 1% of its potential revenue because it has not actually transitioned into the commercialization phase yet. The 99% of its products remain in R&D stage. Sort of like a pharma company.
Silicon Nitride increases osteointrgration, improves imaging, and is antimicrobial (antiviral, antibacterial, antifungal) while being bioactive and biodegradable. That means as it corrodes the material breaks down into materials the body can use. For instance in an aqueous solution, Si3N4 turns into orthosilicic acid which the body utilizes for bone growth. Unlike other materials used in orthopeadic implants, Si3N4 shouldnt accumulate in the body as it can be excreted. Meanwhile Titanium, Trabecular Metal, PEEK, ZTA, all accumulate in the tissue, blood and/or organs. Metals seem to spread through the body while other ceramics and plastics mostly accumulate locally. This is all important to understand when you consider that Si3n4 is destined to replace current materials used in the $64 billion ortho implant industry. As Si3n4 can be used as a coating for metal implants and can be imbued in PEEK materials, it could and should capture almost the entire ortho industry but only though partnerships and licensing.
Markets Si3n4 can be used in (not comprehensive)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Total = $324.36bn
Its honestly overwhelming the size of the markets Sintx material can be used in. Hypothetical scenario using 5% market penetration with a 5% licensing fee equates to $811m in yearly licensing revenue. Thus Si3N4 is worth at least $800m in potential yearly revenue for an acquiring company through licensing revenue according to this scenario. Its ability to penetrate the above markets will vary but Ortho & Catheter markets are markets that Si3N4 should significantly penetrate; with Wound Care & Dental being up there as well. Condom market is more hypothetical based on Si3N4 ability to kill Herpes and possibly other STI. However would need to be studied further to ensure it doesnt impact the delicate microbe balance inside a vaginal canal.
A basic roadmap laid out of Zimmer's intentions for Sintx back in 2011. This quote predates Sintx vast IP portfolio expansion. Any markets Zimmer Biomet does not currently participate in, that Sintx does, represents potential markets Zimmer Biomet can utilize Sintx to bolster its revenue through licensing as well as diversify those revenue sources.
You realize you are disagreeing with something i didnt say because you changed what i said. I said, "You claim to be against these sorts of vulture funds yet your every post is against Sintx/management and therefore in support of those vultures". This means your posts are in support of Anson's family of funds because your posts are only geared against Sintx. I did not say you were in support of Ansons funds even though i think you are based on your posts (even if indirectly). Are you short SINT? Because im long SINT and thus my money is where my mouth is.
If you post against Trump you are in fact indirectly supporting Biden even if you dont want/or will not vote for Biden.
Yes you can flip that around on me but your scenario is wrong. For instance my warrants are in the green for now. I have preferred shares as well that, for the moment, do not convert to many shares. However, if there is future preferred shares issued in a rights offering, i could get a much better conversion price if i am allowed to exchange them for new ones. Sintx has done this before so it could do it again. Thus i have not lost all my money and still stand a chance to make a good amount because of the enormous value here as shown in my last post. My investments are locked up for now, thats a more accurate assessment of my situation. This is what management has done to protect its shareholders against the funds attacking its stock.
Also, i have indicated several times before as long as management and my interests are aligned i support them and so far they are aligned. Sonny has overseen a massive expansion of intellectual property and thus significant increase in shareholder value via Sintx patent portfolio; even if that value is not currrently reflected by the markets. I do not support Sonny taking Sintx private nor do i support him doing any kind of merger with NP Aerospace. If NP Aerospace took a stake in Sintx i could get behind that depending. The reason i do not support Sintx going private is the capital needed to bring products to market is significant. Thus only large public companies can afford that sort of investment. Companies like Zimmer Biomet.
I disagree. The FACT that I'm against one doesn't mean I support the other. We have 2 presidential candidates...
I could play a similar word game with you. You never truly find fault with management, therefore you support what they're doing, including losing all your money.
So Lets examine the value of Sintx and its IP here from a few angles. This should show exactly why Anson's family of funds would be trying to take over Sintx through hostile means. It represents alot of potential money for them if they can succeed.
Transitive Property:
In 2003, Zimmer acquired a materials company for 232m with 108m of it upfront and the remaining 127m coming over the next two years based on sales milestones. Before announcing its partnership with Zimmer, Implex had revenue about the same as Sintx should achieve this year. Its material Hydrocel, Trabeular Metal, could be used for multiple orthopedic implants. Spine, dental, hip, shoulder, and i think knee.
Thus Sintx valuation should be at minimum based on what similar companies are worth: $232m
Accumulated Deficit and Tax Write-off
Sintx Accumulated Deficit = $271.6m. For an acquiring company to utilize this for tax write off purposes Sintx IP would have to be valuable enough to bring in sufficient revenue. However as the cost to acquire Sintx would cost millions between accounting audits, lawyers, golden parachutes, etc.. Sintx accumulated Deficit would likely represent about the same value as what Implex was acquired for to an acquiring company. That is only if Sintx IP couldnt generate more revenue than Sintx deficit. The following will show that it can easily.
Potential Market Size
One particular thing about Sintx is its current sales represents a fraction of 1% of its potential revenue because it has not actually transitioned into the commercialization phase yet. The 99% of its products remain in R&D stage. Sort of like a pharma company.
Silicon Nitride increases osteointrgration, improves imaging, and is antimicrobial (antiviral, antibacterial, antifungal) while being bioactive and biodegradable. That means as it corrodes the material breaks down into materials the body can use. For instance in an aqueous solution, Si3N4 turns into orthosilicic acid which the body utilizes for bone growth. Unlike other materials used in orthopeadic implants, Si3N4 shouldnt accumulate in the body as it can be excreted. Meanwhile Titanium, Trabecular Metal, PEEK, ZTA, all accumulate in the tissue, blood and/or organs. Metals seem to spread through the body while other ceramics and plastics mostly accumulate locally. This is all important to understand when you consider that Si3n4 is destined to replace current materials used in the $64 billion ortho implant industry. As Si3n4 can be used as a coating for metal implants and can be imbued in PEEK materials, it could and should capture almost the entire ortho industry but only with partnerships.
Markets Si3n4 can be used in (not comprehensive and only represents the medical/antipathogenic side of its uses)
Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Total = $276.88bn
Its honestly overwhelming the size of the markets Sintx material can be used in. Hypthetical scenario using 5% market penetration with a 5% licensing fee equates to $692m in yearly revenue. Thus Si3N4 is worth at least $700m in potential yearly revenue for an acquiring company through licensing revenue.
A basic roadmap laid out of Zimmer's intentions for Sintx back in 2011. This quote predates Sintx vast IP portfolio expansion. Any markets Zimmer Biomet does not currently participate in, that Sintx does, represents potential markets Zimmer Biomet can utilize Sintx to bolster its revenue through licensing as well as diversify those revenue sources.
Don't remember denying this (possibly questioning) but I'll own it, if true. I would think that IF I did say this, it was more in line with the belief (something I still have) that Sonny doesn't care about shareholders or their rights. I still believe he's most for himself, evidenced by his salary, perks and non communication with shareholders.
That may very well be true. I have no issue with that thought and if we want to take it a step further, then why not start it up with the CEO that they did? He's doing fine as are all those waiting to collect on the crown jewels, not to exclude the well-informed gamers under the guise of lenders and promoters. The investor on the other hand, who wasn't aware of the predetermined outcome.....
I thing Boston has made it pretty clear that SINT was created to be exploited.
It's a chicken and egg problem...
I am not in the least, defending those like Anson. I despise these types BUT I DO understand their taking advantage, BECAUSE a company is run so poorly. I mentioned in another post that whatever 'illegal' involvement there may be, you can forget the powers that be, from taking action. That's NOT downplaying lousy behavior. What I'm doing is putting the EMPHASIS on the Sints of the world, WHICH make the antics of the Anson types, all too possible and easy. I'm pointing out an evident cause and effect; something you do not do. Btw, I put Maxim in there as well, as I do, Ascendiant (companies Sint does 'business' with). They too wouldn't have such lucrative businesses IF Sint types weren't out there, helping them along with their own stupidity, naivety and in some cases, corruption.
You continue to downplay these funds actions. Why do you attack Sintx yet defend the funds like the Ansons of the world who you claim are simply exposing these companies fraudulent behavior not as publicly claimed, manipulating companies for profit as shown below? Your previous post you indicated that I somehow conveyed Sintx was the first to experience such things and now youve shifted to ive indicated its special in experiencing this. Well it is special, but not in that this is new behavior for Ansons family of hedge funds. Theyve done this before and will again.
Anson Funds and Murchison’s Dirty Partnership – Another Lawsuit: Nano Dimension
I guess I'm one of the "you guys". Let me again be clear as to what I've always said. I cannot prove one way or the other how much or how little things are manipulated concerning stock prices. Sonny's dealings or non-dealings with Zimmer have never concerned me much. Why? Because my firm belief IS and has always been that this company is not investment material. I base that MOSTLY or possibly EXCLUSIVELY on Sonny's handling the CEO position, especially in regards to announcements that don't quite pan out, such as O2 and hey, we're fine financially....only to go majorly to the well not that long afterwards. Tells me, he doesn't understand how to run a public company and probably ANY company IF the desire is to raise cash and investment interest. He turns any TRUE investor off and the Ansons and Maxims on. In my mind, it's quite simple. You run a company like a jerk, other jerks make a jerk out of you. Or if you prefer, expose the jerk you are.
Re my comment about Sint not being the first to go this route: it was meant to show that ALL clown shows pay a similar price, not just Sint. THIS is what you call disinfo or misinfo, but it isn't. EVERY company I've seen run it's shop in similar fashion to Sint, meaning they APPEAR clueless, gets taken advantage of. Sint is and was no different. Otoh, you have often made it sound as if a "special" conspiracy has been launched against Sint. I couldn't disagree more! I've seen it all too often.
no, it means I ignore the rest of your monotonous, self-absorbed blather....
ROFLMFAO
Of all what i posted thats the only thing you take issue with? Guess that means you agree with the rest. Let me expand on what i was saying as i didnt mean Sonny is literally watching ihub. Companies routinely have employees that check social media boards and i have found that some of that information get passed upward. Like when i posted the 30 year study out of Australia on implanted Silicon Nitride spinal implants that were implanted before Sintx founding. As far as i know Sonny wasnt aware of that study until i posted it here but he referenced that study after i posted it here on a later a conference call i believe. Same thing has happened on the Teslas board. Musk has actually posted or said things that appear to be associated with something i posted on that board beforehand. Do i think Musk read what i posted? No. I think word got to him though. Outside of that im nobody, just a messenger.
========================================
Someone on cafepharma is claiming that Dr ZB got inside info from CTL but it looks more likely that he got it from Anson's family of funds because Dr ZB is a cardio surgeon not a spinal surgeon. Tenax drug shows promise in being used for cardio surgeries so who better to provide insight/consulting services than a cario surgeon? Thus its more likely he passed info to Hudson Bay, et al and they told him about SINT than Chon told Dr. ZB about SINT. As i said already, all four companies Dr ZB invested in over a 1 year period, were companies that Hudson Bay or any of the Anson family of funds were/have invested in.
"..Sonny or any others watching..."
you are SO full of your own self-importance, buddy.....
ROFLMFAO
Do i stop it? No. Only thing i can do is shine a light on the problem and Sonny or any others watching can do what they will with the information. My post about Dr ZB is more about how these funds work and i believe helped create an aura of trading as to cover the insider trading, than Dr Binsalamah himself.
I dont know where you get the idea ive claimed or think that Sintx is the first to go down this road?
You guys claimed Zimmer Biomet wasnt their strategic partner, i proved it was.
You guys claimed there was no short and distort conspiracy here, i proved there has been.
Ive claimed that Tesla is a fake it until it makes it scam and now its under investigation for that sort of behavior.
Ive shown flying saucers are in fact manmade first designed by Viktor Schauberger in the 1930s.
Ive even shown the reason that 9/11 was a false flag (So the US could leave the 1973 ABM treaty).
Boston, even if you're 100% correct, how do you stop it? Do you think Bal and co. are the first to go down in this cesspool of never ending shorting games, reverse splits and offerings? Like I said, these guys are professional vultures and they take advantage of every unsuspecting startup; not to mention those who willingly go along with them. The real losers ARE always those who believed and invested.
A real culprit in all of this is the SEC who despite making billions on fines, can't seem to ever get the right personnel (or laws) to finally stop this crap. What we need is Congress to pass laws that work! Oops, almost forgot...they benefit as well, by keeping things just the way they are.
Looking into the matter of inside trading i have uncovered the following:
Dr Ziyad Binsalamah is a Thoracic Surgeon (Cardiothoracic Vascular Surgery) that was practicing in Houston Texas at the time. One of Anson's funds is located in Houston area.
Hudson bay files a 13G in Tenax Feb 2019.
March 2019 Tenax reveals that it has begun phase 2 trial of its drug
May 2019 Dr Binsalamah begins investing in Bridgeline Digital
August 2019 Tenax provides business update revealing top line data Q1, 2020
April 2020 Tenax provides update that its topline data is due late June 2020
Dr. Binsalamah buys shares May 2020. Sells when the price pumps on topline data release June 2nd.
Same day he sells Tenax he buys SINT for which he sells SINT on its price pump June 22nd.
July 2020 Dr Binsalamah begins buying Interspace Biosciences for which he closes his position August 2020 about a month later for a 30-40% loss.
Dr Binsalamah has not filed further 13Gs since.
My interpretation of the above information suggests that Hudson Bay or any of its family of funds contacted Dr Binsalamah to provide consulting services and possibly keep track of trial progress; trial was not at a Hospital in Texas so its not likely Dr Binsalamah had direct access to data. Being a Cardio surgeon he could befriend or associate with the doctors using the drug at one or more of the 10 hospitals. In exchange, it seems, Dr Binsalamah would be given information to profit from trades. To accomplish this without raising red flags he traded four companies that were all associated with Hudson Bay. First was Bridgeline Digital for which he traded for a year. This company i believe was to establish his trading profile. Then he did two quick trades in Tenax and SINT for large profits. Under this hypothesis this represents the core of his compensation for information/consulting services. His final trade was in Interspace Biosciences where he traded over a month and seemingly took a loss...assuming he wasnt short in another account. Since these 3 of these trades were all short lived it could raise red flags for insider trading. Thus by taking a loss in his Interspace investment, it helps provide cover. I contend all three trades outside of Tenax were meant to help establish Dr Binsalamah as a trader and help cover inside information he may have had from contacting Doctors associated with Tenax trial. As all four funds are associated with Hudson Bay and Ansons family of funds, it looks like an exchange of information was done. I do not see any reason for Dr. Binsalamah to be associated with Sintx.
Data source:
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&filenum=005-58467&type=&dateb=&owner=include&start=0&count=40
https://clinicaltrials.gov/study/NCT03541603#contacts-and-locations
https://investors.tenaxthera.com/news
https://sec.report/CIK/0001783976
========================================
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years. A conspiracy of shorting and distorting.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544
I go into some of the evidence of this in the February 2023 offering where they drove the price up & naked shorted it down. Ansons family of funds participated in every offering in 2023 up to the recent RS. Anson and the other funds its associated with are known for their short and distort actvity and are under investigation by the DOJ. SEC slapped it with a ticket fine basically that will in no way discourage its shorting and distorting methods.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174602472
========================================
The Value being created at Sintx can be seen in the following posts and links:
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
In light of the recent revelation that there has been a conspiracy of funds shorting and distorting SINT/AMDA since 2015, the following information suggests that these funds were still in the background in 2020 when Dr Ziyad Binsalamah invested for the 2020 pump. The fact that Dr Binsalamah was invested for the duration of the pump, just before it began, suggests he was given inside information. Informational compensation for services or information given? Did Dr. Binsalamah give out some inside information to Anson family of funds? I am curious how Dr. Binsalamah is connected Ansons family of funds which Hudson Bay Capital is but one? I originally posted this in 2022. I suspect alot of compensation to those associated with pumping and dumping/shorting & distorting are compensated with information they can make alot of money with rather than traditional payments.
All 4 of the stocks Dr ZB invested in were or are associated with Hudson Bay Capital, a known vulture fund. My guess is hes an associate of that fund, maybe part of the pump and dump scheme they run. 2 of the 4 he shows up for under a month for a pump and dump. Sintx & Tenax which had good phase 2 outcome. There's no way every company he happens to jump into is or was associated with Hudson Bay. Just so happens, Hudson Bay was one of the funds from 2015 that held shares in Amedica now Sintx.
Sintx:
Only four funds among those we track were long Amedica Corporation (NASDAQ:AMDA) at the end of 2015. Among them was Sander Gerber’s Hudson Bay Capital Management, which declared holding 3.77 million shares worth $423,000 as of December 31. It should be noted that following a 1:15 reverse stock split in January, Hudson Bay’s stake should amount to roughly 251,131 shares now.
https://www.insidermonkey.com/blog/why-disney-dis-amedica-amda-cvent-cvt-unipixel-unxl-and-repros-therapeutics-rprx-are-spiking-today-444128/
Tenax
https://www.sec.gov/Archives/edgar/data/1378590/000139382519000047/0001393825-19-000047-index.htm
Bridgeline
https://www.sec.gov/Archives/edgar/data/34956/000139382519000103/0001393825-19-000103-index.htm
Interpace Biosciences
https://www.sec.gov/Archives/edgar/data/1054102/000143774917005108/idxg20170322_8k.htm
Hudson Bay Capital Management is a fund that has previously settled SEC charges for securities laws violations and has been linked to an ongoing investigation relating to an alleged pump and dump ring.
https://utopiacap.com/hudson-bay-capital-management/
Binsalamah Ziyad
SEC CIK #0001783976
https://sec.report/CIK/0001783976
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170339659
Noneya, you arent all about the truth but i will give you that you do use the truth the most of those bashing Sintx. However you do tend to use truth to tell lies, use implication to give wrong impression, and other methods of distortion which you put under the umbrella of "sarcasm". Your posts about where are these products is factual but purposefully misleading. If your intent is not to mislead then i suggest the word "When". When are these products going to be commercialized not where are they which implies they failed or not forthcoming one day. If you are really curious about products like wound care please look at their recent presentation and 10k filing. Ive linked them for you.
https://ir.sintx.com/company-information/presentations
I believe what your saying is possible just trying to better understand it. I recall in my research on Anson's family of funds it was claimed that the SEC issued such a small fine to save face and protect the blue chips that these funds seem to be associated with (hearsay). In terms of Ortho that could easily mean J&J is behind the scenes. Course Zimmer could be as well if it wanted to protect the IP by trying to keep it under wraps. 'Which could explain why Zimmer's name was removed from IPO paperwork.
Since i have not seen any hard evidence connecting Anson's family of funds to a specific blue chip thats interests are served by it shorting and distorting Sintx, i am not ready to declare thats whats been happening. It would explain so much about why this is sooo undervalued though. Regardless of whomever interests Ansons family of funds might be serving.
========================================
In typical distort behavior NoneyaBiz over on ST is implying Sintx imbuing of fabrics and its associated products, have all failed despite the 10k indicating the products are being created with strategic partners. One such partner appears to be Cardinal Health.
https://stocktwits.com/NoneYaBiz61
The first thing that pops into my mind is to maximize ip control.
Not prepared to argue it, but it seems plausible based on what I understand of this situation.
I've heard something like this before. The tech is being held back as to not rock the boat too hard for the markets that Si3N4 will disrupt. Why would that be the case when Si3N4 can be used to enhance current materials through coatings and imbuing PEEK?
Repost - see replied to post:
This is essentially how the Anson family of funds (is Anson at the top of this family?) work SINT and its offerings.
Here is a trade that is almost guaranteed to make money, though it is also double super illegal.
Repost, see replied to post:
It appears that SiNtx is controlled financially by scammers that won't allow the tech into the market until they've milked every penny they can out of old drugs the shift will be sudden and violent.
Your point about accumulated deficit is significant, IMO.
SINTX VP of R&D, Dr. Ryan Bock, and Associate Scientist, Ms. Tabitha Derr, participated in the 2024 Implant Polymers UHMWPE & PEEK Conference in Barcelona, Spain, June 20-21. This conference, organized by SINTX collaborator Prof. Steve Kurtz of the Drexel Implant Research Core, is the premier meeting for discussing developments related to PEEK implantology, including composites and additive manufacturing. Ms. Derr presented a poster and delivered a short talk on her work related SINTX’s NIH-funded additively manufactured SN-PEKK CMF implant project, while Dr. Bock communicated a podium presentation describing the benefits of silicon nitride as a composite constituent and highlighted its inclusion in additively manufactured SN-PEEK spinal implants and SN-coated additively manufactured carbon fiber reinforced trauma plates as part of two NIH-funded development programs.
biennial conference brings together major material suppliers, printer manufacturers, and academicians in this space, which allowed us to catch up in person with all of our current collaborators and forge new relationships over a very busy two days.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Bird flu map shows unprecedented spread as expert warns future pandemic inevitable
The Centers for Disease Control and Prevention says the risk to the general public is “low” but it is “watching the situation carefully and working with states to monitor people with animal exposures.”
Since 2022 there have been four reported human cases, the most recent three - all this year - following exposure to infected dairy cows. The risk is tempered by the fact that it doesn’t spread easily among humans.
But public health officials fear that could change. Just recently former CDC director Dr Robert Redfield told NewsNation: “I really do think it’s very likely that we will, at some time, it’s not a question of if, it’s more of a question of when we will have a bird flu pandemic.”
And writing in the New York Times, Dr Jennifer B Nuzzo, an epidemiologist and director of the Pandemic Center at the Brown University School of Public Health, warned that the virus “could mutate to gain the ability to infect people more easily.”
That would “likely cause a new pandemic.” With the disease proving fatal in around half of the nearly 900 people known to have contracted the H5N1 strain of the virus worldwide since 2003, bird flu is “typically more dangerous than the viruses that cause seasonal flu and COVID-19.”
Meanwhile, outbreaks of H5N1 have been detected in 525 counties and 48 states. The CDC says almost 97 million birds have been affected since January 2022 when the first H5 viruses to be found in the US since 2016 were detected.
The virus has also spread to 92 dairy cow herds in 12 US states.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
AMDA you also said explore for alternative which implies they have to go looking for something, in desperation, instead of exploring options that might already be on the table. Yes they could have options already on the table with strategic partners. Youre purposefully changing what was said regardless if you work in tandem with Ansons conspiracy of funds or not. Something you also claimed wasnt going on. Evidence shows otherwise.
You guys keep acting like im crazy despite the evidence showing otherwise. Evidence shows the medical device market is 64b in size and that Sintx Silicon Nitride is destined to one day replace current biomaterials. If it has the partners why couldnt this be true? Catheter market is apparently 55bn in size with significant problems related to both bacterial and fungal issues for which a Si3N4 coating could help prevent. Again why wouldnt Sintx Silicon Nitride not capture a large share of both of these markets if the product does what scientific studies shows it can do? Im not claiming Sintx can do it by itself but utilize the strategic partnerships it already has in place. What am I missing? Sonny is patenting the tech like crazy for a reason. 150 freaking patents pending worldwide. That seems like alot of patents for tech that cant do whats claimed.
Their collaborative study is the first to show how the fungus Candida albicans infects the catheterized bladder. Fungal infections are difficult to treat and represent a significant and growing public health concern around the world.
Catheter-related blood circulation infection is the most dangerous and serious side-effects of vascular catheters, which leads to the enhancement of the costs, mortality, and hospital stay duration, especially in the Intensive Care Unit.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Tisk Tisk AMDA. Here is evidence of distorting the facts, part of the short and distort campaign here:
the disturbing part is that they have to "explore" for alternatives. according to that boston guy, the hidden value here is so great that you would think potential partners/suitors would be beating down Sonny's door - not the other way around. there is total denial/insanity in New England....
“With technologies targeted at the medical, defense, and renewable energy markets, year-over-year growth in revenues, and other commercial opportunities in the pipeline, SINTX will require additional investment and resources. As such, we want to examine all strategic opportunities targeted at maximizing shareholder value,” said Sonny Bal, Chief Executive Officer and Chairman of SINTX. “We believe that potential partners will find significant value in SINTX’s businesses and capabilities.”
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
243b x .05 market penetration x .05 licensing fee = $607m a year revenue. You dont think $607m revenue is easily worth paying $1.2b for? This said i expect Si3n4 to penetrate into those markets more than simply 5%. Specifically the Catheter and Ortho markets where it should extensively capture because it can be coated and imbued on current materials if not replace them entirely while bringing its antipathogenic properties and increased bone cell stimulation or osteointegration to those products. Because Si3n4 is anti all pathogens it could easily capture much larger share than 5% of the antibacterial market but i havent seen the scientific data of how effective Si3N4 is added to these soaps. As Si3N4 is soluble it does break down overtime. Which could be a good or bad thing. Does it retain its ability to kill pathogens is the key for the antibacterial market?
In addition to Zimmer Biomet former CEO being the current CEO of Solventum with knowledge of Si3N4, Sintx also hired a VP with connections to 3M before Solventum was spun off. Marcroft also has ties to Medtronic, as does Sonny who consulted for Medtronic in addition to Zimmer, and Boston Scientific. Medtronic should be very interested in Catheters and Si3n4 imbued PEEK products just to name two products. Remember Sintx is a licensing play pure potential play. Even if Zimmer acquires it one day Si3n4 will not be restricted to simply Zimmer's share of the market. Plus thats what Zimmer wants Sintx for, licensing revenue!
https://ir.sintx.com/news-events/press-releases/detail/165/sintx-technologies-appoints-michael-marcroft-as-vice
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Thanks for answering via the rights offering. I agree that there needs to be management participation in the buying of shares. As for the short and distort campaign, that is up to leadership. If they put something out that would put fear in the shorters (such as viable news releases on money-making partnerships....meaning millions, not thousands), the shorts will disappear fairly quickly. Only dummies and 'gamblers' continually short winners....
To add to my post about NP Aerospace, here is this part from Tuesdays Press Release. Other proprietary technologies include the manufacture of high performance, lower cost ballistic materials for opaque armor applications at its subsidiary, SINTX Armor. SINTX Armor is expected to begin production of a competitively priced body- and vehicle-protective armor product that has undergone successful testing.
This was likely what Sintx and NP Aerospace have been waiting for in regards to some sort of announcement between the two.
========================================
To your so called deflections Joe, my last post specifically indicated that i participated in shareholder rights offering and ive said as much since the 2022 offering. To do so i had to be a shareholder already. I added it after posting that post during the 15min edit window and added it to the wrong paragraph; maybe you just missed it.
Participating in shareholder rights offerings is one way and what i have done.
In regards to this weeks press release, i hope its indication that one of their strategic partners is going to take a stake in the company. Either that or that they will sell the armor division to NP Aerospace.
SINTX Technologies to Explore Strategic Opportunities
https://ir.sintx.com/news-events/press-releases/detail/233/sintx-technologies-to-explore-strategic-opportunities
NP Aerospace needs a US based manufacturing plant and it uses the exact armor materials that Sintx Armor provides. Donald Bray, Consultant/former VP at Sintx & Morgan Ceramics, oversaw NP Aerospace division before it was divested Nov 2018. 6 months later he was hired at Sintx, April 2019 (6 month non-compete?). This suggests one of the reasons he was brought on, possibly sent, to Sintx was to help Sintx receive ISO 9001 certified facilities so it could produce goods for defense and aerospace applications. IE, supply Morgan Ceramics in Aerospace and NP Aerospace in armor. Morgan Ceramics has been a strategic partner of Sintx since 2016.
NP Aerospace currently has manufacturing locations in England and Canada with only a sales presence in Florida. It could either acquire Sintx armor or simply setup a joint venture. US represents a significant market of interest and target for expansion for NP.
Non-compete
Most states follow the doctrine of “equitable reformation," which enables contracts to be upheld with revisions. For example, a contract that originally lasted five years after an employee's termination may be amended to last for only six months with all other provisions in place.
The outer ceramic armour layer 2 may be segmented armour and may comprise tiles or pellets of ceramic and the ceramic may be of any ballistically suitable type, including without limitation; alumina, silicon carbide, boron carbide, and composite ceramics. Typically the thickness is greater than 4 mm, but thickness depends on threat level.
The expansions we are forecasted to see in 2022 are likely to open up some opportunities for us in the long term, to do some really strategic acquisitions in key markets, which in turn will act as a catalyst for faster growth in certain regions. That potential is certainly there for us in the US, which is very exciting,” James concludes.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Deflect, deflect, deflect....
Deflection A) Folks, notice there's no comment as to personal involvement in a losing investment, ongoing year after year, yet there remains a continual flow of support for management and supposed value. Why?
Deflection B) attention is drawn to company's alleged billion dollar+ value but NO explanation as to how it can possibly get there under present circumstances i.e. reverse splits, dilution and management being in bed with the vulture crowd all the time.
Deflection C) The usual accusations of distorting and shorting, while ignoring truths as to why the company is and remains in the position it's in, along with the FACT that WHEN investors DO SHORT continually at such a high percentage (as is the case here) they do it because NO ONE CONSIDERS the company a worthwhile investment. This he considers a collusive distort and short campaign.
Truth is folks, people and institutions are just using common sense. If an investor sees a company that's crap, they either ignore it (institutions) or short it (professional shorters and gamers). Showing the smallest of interest as is mentioned frequently here, is nothing more than throwing a buck down on a lottery ticket. Real issue here (always ignored) is WHY doesn't ANYONE invest? Literally NO ONE invests here. That is the point a 'true' believer and investor would want addressed, but would never be by a paid shill. Instead we get accusations and innuendos directed at those who are simply pointing out the obvious. Talk about a distortion campaign lol......
NO ONE WANTS SINT! NO ONE BELIEVES SINT or IN SINT. From management to institutions to accredited lenders to individuals....NO ONE sees true value here and so purported value is made up by an individual based on the purchases of lottery tickets by powerhouse institutions and the like.
Im not going to get pulled into an attempt to create more forum verbiage to drown out good information. Plus im limited to 3 posts a day for going on 9 months now. Yes you've employed a lot of methods of disinformation in your posts. Like TA over on ST, youre good at projecting things you yourself are doing.
When i commented that youve been here for 8 years it means you should know a thing or two about the markets Sintx can participate in. Thus you could give some insight if you wanted as to the potential/value of Sintx Intellectual Property. The fact that you do not want to...is telling. It means you do not want to incriminate yourself or arm me if you agreed; although your original 1-10b spread maybe your attempt at an honest answer. 50b is ridiculous which is likely why you are ok with me saying you believe that. $270m has been spent developing Sintx IP over the years and thus $1.2b represents a decent ROI on that. 10x return would be 2.7b which is about 1% of Sintx addressable markets. However because SINT is so undervalued, those funds can buy super cheap and make back shareholder investment that way allowing SIntx to be acquired for far less than its IP is worth. It'll be interesting if this is how things play out... Still 270m is tax credit offset representing a sizable credit to potential acquiring company. Sintx has a superior/disruptive product that can sell into very large markets and no debt. Thats extremely rare to find at a company worth so little. Thus investors need to protect their investment. Participating in shareholder rights offerings is one way and what i have done.
I completely acknowledge that there is no tute with a large stake in Sintx. This part has evidence supporting it. Having said that, the fact that major funds, mostly connected to Zimmer Biomet, have had small stakes in Sintx for pretty much the entire time we've been here, does not suggest lack of interest as you like to imply. It suggests they are keeping an eye on Sintx but something holds them back (most important funds are Blackrock and Wells Fargo as both are major investors of Zimmer & Biomet before merger). While those funds have been in the background, SINT has been under a short and distort campaign for 9 years now, proof below. As long as those funds & management stay in the background, this short and distort campaign seems likely to continue.
Heres 4 markets Sintx can participate in to give an idea of potential worth. Mind you Sintx can play in more markets than this:
Global Ortho device market = $64bn by 2025
Global Catheter market = $55bn in 2023
Personal Protective Equipment market = $79.53 billion
Antibacterial market = $44.5bn 2024
Right there thats a maximum of $243bn in just 4 markets. This doesnt include Dental implant market, Wound Care market, Oncology market via Cancer treatment applications and so many other markets Sintx could participate in. Hell im surprised Musks Neuralink hasnt tapped Sintx as the material would help with implantation both in reducing infection as well as reducing toxic corrosion.
People may look at this and think its ridiculous because Sintx is worth like 4.2m but its material is destined to replace current biomaterials in the ortho market. Its antiviral, antibacterial, antifungal so great product for catheter and PPE markets. Assuming it can be imbued in soap solutions obviously it would be great for the antibacterial markets as well. Its shows effectiveness against all ss-RNA viruses including Bird Flu & Covid. As well as they found its effective against herpes which is a double stranded DNA virus meaning it could be effective for the 10b condom market to help slow the spread of STIs.
Instantaneous Inactivation of Herpes Simplex Virus by Silicon Nitride Bioceramics
https://www.mdpi.com/1422-0067/24/16/12657
Funds watching Sintx:
https://fintel.io/so/us/sint
My post on markets Sintx can participate in with valuations and evidence:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174624826
Proof of short and distort campaign being waged against Sintx/SINT below.
Methods of Disinformation commonly being used in posts that are overly negative on Sintx. If those posting overly negative posts against Sintx were right, they wouldnt need to use disinformation tactics. They could just stick to the facts. They lack substance outside of things they can manipulate via the markets.
https://web.archive.org/web/20231004223836/https://www.ethosdebate.com/lies-rhetoric-4-18-rules-disinformation/
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
wow - you've gotten sucked down into the closed loop vortex of New England insanity.
nothing can escape the gravitational pull of a black hole - I wish you God speed.....
TA I don't know if this individual is a compensated shill or not, but if he isn't, he's most definitely the most stubborn, arrogant individual I've ever had a back and forth with on these boards. I've yet to hear him admit true wrong by himself or the company. Constant deflection along with the aim to steer the narrative in only one direction is his forte'. I'm sure the PERSONAL content of a post such as this, will be what he ONLY addresses, along with the other 17... Oh, and of course Bal's success and Sint's true worth....apparently missed by just...everybody else... LOL.
Hey Boston, would you care to divulge how much you have invested here, lost, or are willing to invest further? Seems kind of strange with all the accusations and innuendos from your side towards those opposing your views, that I have yet to see any numbers of anything invested coming from your end. Gives credence to the shill pov, imo.
Like I've said, you deflect, deflect, deflect. You have no interest in discussion, only in people agreeing with your views. I don't and won't because Sint remains a loser based on tons and tons of evidence that you willfully ignore. I have zero interest in delving deeper and deeper into doo-doo, okay? It makes no difference to me whatsoever (as I've stated many times) what Sint is or isn't intrinsically worth. So feel free to tell people I believe Sint is worth 50 billion. I don't care! Maybe it's true as well, okay?
Whether or not Bal got in bed with the wrong people on purpose or by ignorance and naivety (You'd be surprised how many startup ceos are ignorant of the vultures that surround them), the truth is he did and the results are the same for virtually every company which has done the same: a never ending death spiral. THAT is a FACT you continually and willfully ignore. And so you keep trying to rope people like myself into agreeing what a great company Sint is or will be or should be. No one listens or agrees. Doesn't matter what you say they SHOULD be worth.
They blew their chances long ago when they (for whatever reason) got into the death spiral routine thanks to the likes of Maxim and similar. And here they are, and here you are....longer than my eight years, but still spouting the same stuff that has gotten you nowhere, the company nowhere and the investment community nowhere. However, I'm sure some are travelling much lighter these days, thanks to their following your advice and/ or believing in Bal's leadership abilities.
Now feel free to once again post how I'm using disinfo tactics, personal attacks or posting negative stuff. Truth is, there's hardly a thing that isn't negative about Sint, including the alleged positives that are anything but, to the investor. Ask Bal. His supposed 1 million entry early on, leads me to believe he was duped by the Ascendiant and Maxim types (like many CEOs are) but to his credit, he has since learned. However, his disdain for fellow investors hasn't exactly endeared him, nor has his rewarding himself with bonuses for performance which is nothing short of horrendous (except to you). Enjoy ranting on my friend. I'll still probably respond in some fashion because I don't enjoy people losing their money (unless they refuse not to).
You've been posting here for about 8 years and have claimed to have invested in several stocks through the years. I think you can do better than I dont know. I dont know is the same as saying no comment without actually saying no comment which is a more evasive answer. A more honest answer would have been to say that you could see scenarios where its worth over 1 billion with the right commercialization partners. We both know Sintx depends on strategic partnerships for commercialization purposes.
Lets look at 4 markets Sintx can participate in to give an idea of potential worth. Mind you Sintx can play in more markets than this:
Global Ortho device market = $64bn by 2025
Global Catheter market = $55bn in 2023
Antibacterial market = $44.5bn 2024
Personal Protective Equipment market = $79.53 billion
Right there thats a maximum of $243bn in just 4 markets that Sintx can play in with antibacterial market being more murky as to if Si3N4 would be used in soaps and such. Thus Sintx need only achieve 1% market penetration to get to $2.4bn and .5% penetration to get to $1.2bn. As Sintx Silicon Nitride is destined to replace titanium and other biomaterials, i'd say its penetration of the ortho market alone would be way more than 1%. Given how effective Si3N4 is against different pathogens it should penetrate into the the catheter market far greater than 1% as well. So yes Sintx IP could easily justify being worth more than $1 billion specifically in the ortho device, catheter, & PPE markets. All the while Sintx current market valuation is ~$4.3m right now (best estimate based on 750k OS).
Orthopedics market set to reach $64bn by 2025 as acquisitions surge, says GlobalData
https://orthospinenews.com/2021/01/22/orthopedics-market-set-to-reach-64bn-by-2025-as-acquisitions-surge-says-globaldata/
The global catheter market size was estimated at USD 54.68 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.57% from 2024 to 2030.
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
Global antibacterial products market size is expected to reach $56.62 Bn by 2028 at a rate of 6.2%
https://www.thebusinessresearchcompany.com/report/antibacterial-products-global-market-report
The global personal protective equipment market size was over USD 79.53 billion in 2023 and is anticipated to grow at a CAGR of 7.2%
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
I did comment. Read my message again. I said I don't know. I do know that whether it's worth a billion or even 10 billion, it's not bringing in investors or accredited lenders. That should concern you.
I even asked Joev2 if he thought that Sintx IP could be justifiably worth more than $1 billion for which he will not comment
Followers
|
240
|
Posters
|
|
Posts (Today)
|
6
|
Posts (Total)
|
41295
|
Created
|
02/13/14
|
Type
|
Free
|
Moderators Atlanta1 Tesla thru the roof |
https://www.youtube.com/watch?v=j94SgeyCh3M
(AMDA) Amedica Corp. - NASDAQ
RECENT NEWS
https://www.youtube.com/watch?v=hxbj7Sq7W94
https://www.youtube.com/watch?v=j94SgeyCh3M
https://www.youtube.com/watch?v=KbU47COpXx8
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |